In Brief This Week: 454 Life Sciences; Waters; Agencourt; Illumina; Pathwork Diagnostics; and More | GenomeWeb

NEW YORK (GenomeWeb News) – Roche's 454 Life Sciences said this week that its Genome Sequencer FLX has been installed at the University of Barcelona in Spain. The university's Genomics Unit of the Scientific and Technical Services will use the platform to study aquaculture and DNA alterations related to human diseases.


Waters said that the National Cancer Institute's Center for Cancer Research has purchased an Acquity UPLC/Synapt HDMS system and an Acquity UPLC/Xevo TQ MS system for use in its metabolomics research programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.